Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study
Xueling Zhu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Biao Zhu(Swiss HIV Cohort Study), Zhikai Wan(National Centre for Infectious Diseases), Jiangjin Hui(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Xiaorong Peng(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Ran Tao(Vanderbilt University Medical Center), Ying Huang(Swiss HIV Cohort Study), Xiang Liu(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Junwei Su(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases)
Cited by 1
Related Papers
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders
|Nature Communications|2021|107
Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective
|Aging and Disease|2021|80
One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection
|BMC Medicine|2021|80